Immune globulin and vaccine therapy to prevent hepatitis A infection

American Journal of Medicine

Volumn 105, Issue 5, 1998, Pages 416-423

  Levy, Michael J ^a   Herrera, Jorge L ^a   DiPalma, Jack A ^a,b  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A VACCINE; IMMUNOGLOBULIN;

ANTIGENICITY; ARTICLE; HEPATITIS A; HEPATITIS A VIRUS; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; PASSIVE IMMUNIZATION; POPULATION EXPOSURE; PRIORITY JOURNAL; PROPHYLAXIS; VACCINATION; VIRUS INACTIVATION; VIRUS TRANSMISSION;

EID: 0032211490     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00296-4     Document Type: Review

References (97)

1. 1. Bader TF. Hepatitis A vaccine. Am J Gastroenterol. 1996;91:217-222.
2. 2. Corey L, Holmes KK. Sexual transmission of hepatitis A virus in homosexual men. NEJM. 1980;302:435-438.
3. 3. Lemon SM, Thomas, DL. Vaccines to prevent viral hepatitis. NEJM. 1997;336:196-204.
4. 4. Margolis HS, Alter MJ. Will hepatitis A become a vaccine-preventable disease? Ann Intern Med. 1995;122:464-465.
5. 5. Siegl G, Lemon SM. Recent advances in hepatitis A vaccine development. Vir Res. 1990;17:75-92.
6. 6. Lemon SM, Jansen RW, Brown EA. Genetic, antigenic, biological differences between strains of hepatitis A virus. Vaccine. 1992; 10(suppl 1):S40-44.
7. 7. Koff RS. Seroepidemiology of hepatitis A in the United States. J Infect Dis. 1995;171(suppl 1):S19-23.
8. 8. Lee KK, Vargo LR, Chinh TL, Fernando L. Transfusion-acquired hepatitis A outbreak from fresh frozen plasma in a neonatal intensive care unit. Pediatr Infect Dis. 1992;11:122-123.
9. 9. Centers for Disease Control. Prevention of hepatitis A through active or passive immunization; recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1996;45: 1-30.
10. 10. Hadler SC, McFarland L. Hepatitis in day care centers: epidemiology and prevention. Rev Infect Dis. 1986;8:548-557.
11. 11. Krugman S, Giles JP. Viral hepatitis: new light on an old disease. JAMA. 1970;212:1019-1029.
12. 12. Goodman RA, Carder CC, Allen JR, Orenstein WA, Finton RJ. Nosocomial hepatitis A transmission by an adult patient with diarrhea. Am J Med. 1982;73:220-226.
13. 13. Skinhoj P, Mathiesen LR, Kryger P, Moller AM. Faecal excretion of hepatitis A virus in patients with symptomatic hepatitis A infection. Scand J Gastroenterol. 1981;16:1057-1059.
14. 14. Mbithi JN, Springthorpe S, Boulet JR, Sattar SA. Survival of hepatitis A virus on human hands and its transfer on contact with animate and inanimate surfaces. J Clin Microbiol. 1992;30:757-763.
15. 15. Reybrouck G. Handwashing and hand disinfection. J Hosp Infect. 1986;8:5-23.
16. 16. Fox MK, Langner SB, Wells RW. How good is handwashing practice? Am J Nursing. 1974;74:1676-1678.
17. 17. McCaustland KA, Bond WW, Bradley DW, Ebert JW, Maynard JE. Survival of hepatitis A virus in feces after drying and storage for 1 month. J Clin Microbiol. 1982;16:957-958.
18. 18. Mbithi JN, Springthorpe VS, Sattar SA. Effect of relative humidity and air temperature on survival of hepatitis A virus on environmental surfaces. Appl Environ Microbiol. 1991;57:1394-1399.
19. 19. Doebbeling BN, Li N, Wenzel RP. An outbreak of hepatitis A among health care workers: risk factors for transmission. Am J Public Health. 1993;83:1679-1684.
20. 20. Frosner G. Hepatitis A virus. In: Belshe RB, ed. Textbook of Human Virology. Littleton, Massachusetts: PSG; 1984:707-727.
21. 21. Centers for Disease Control. Safety of therapeutic immune globulin preparations with respect to transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR. 1986;35:231-233.
22. 22. Centers for Disease Control. General recommendations on immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 1994;43:1-38.
23. 23. Steffen R, Kane MA, Shapiro CN, Billo N. Epidemiology and prevention of hepatitis A in travelers. JAMA. 1994;272:885-889.
24. 24. Steffen R. Risk of hepatitis A in travellers. Vaccine. 1992;10(suppl 1):S69-72.
25. 25. Stokes J, Neefe JR. The prevention and attenuation of infectious hepatitis by gamma globulin: preliminary note. JAMA. 1945;127: 144-145.
26. 26. Mosley JW, Reisler DM, Brachott D, Roth D, Weiser J. Comparison of two lots of immune serum globulin for prophylaxis of infectious hepatitis. Am J Epidemiol. 1968;87:539-550.
27. 27. Ellis EF, Henney CS. Adverse reactions following administration of human gamma globulin. J Allergy Clin Immunol. 1969;43:45-54.
28. 28. Andre FE, Hepburn A, D'Hondt E. Inactivated candidate vaccines for hepatitis A. Prog Med Virol. 1990;37:72-95.
29. 29. Innis BL, Snitbhan R, Kunasol P, et al. Protection against hepatitis A by an inactivated vaccine. JAMA. 1994;271:1328-1334.
30. 30. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. NEJM. 1992;327:453-457.
31. 31. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med. 1996;150:733-739.
32. 32. Lemon SM, Binn LN. Serum neutralizing antibody response to hepatitis A virus. J Infect Dis. 1983;148:1033-1039.
33. 33. Product insert. HAVRIX hepatitis A vaccine. SmithKline Beecham Pharmaceuticals. 1995. Philadelphia, Pennsylvania.
34. 34. Tilzey AJ, Palmer SJ, Barrow S, et al. Effect of hepatitis A vaccination schedules on immune response. Vaccine. 1992;10(suppl 1): S121-123.
35. 35. Leentvaar-Kuijpers A, Coutinho RA, Brulein V, Safary A. Simultaneous passive and active immunization against hepatitis A. Vaccine. 1992;10(suppl 1):S138-141.
36. 36. McMahon BJ, Williams J, Bulkow L, et al. Immunogenicity of an inactivated hepatitis A vaccine in Alaska Native children and Native and non-Native adults. J Infect Dis. 1995;171:676-679.
37. 37. Horng YC, Chang MH, Lee CY, Safary A, Andre FE, Chen DS. Safety and immunogenicity of hepatitis A vaccine in healthy children. Pediatr Infect Dis J. 1993;12:359-362.
38. 38. Wiedermann G, Ambrosch F, Andre FE, D'Hondt E, Delem A, Safary A. Persistence of vaccine-induced antibody to hepatitis A virus. Vaccine. 1992;10(suppl 1):S129-131.
39. 39. Wiens BL, Bohidar NR, Pigeon JG, et al. Duration of protection from clinical hepatitis A disease after vaccination with VAQTA. J Med Virol. 1996;49:235-241.
40. 40. Van Damme P, Thoelen S, Cramm M, De Groote K, Safary A, Meheus A. Inactivated hepatitis A vaccine: reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol. 1994; 44:446-451.
41. 41. Wagner G, Lavanchy D, Darioli R, et al. Simultaneous active and passive immunization against hepatitis A studied in a population of travellers. Vaccine. 1993;11:1027-1032.
42. 42. Ellerbeck EF, Lewis JA, Nalin D, et al. Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A. Vaccine. 1992;10:668-672.
43. 43. Andre FE, D'Hondt E, Delem A, Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine. 1992;10(suppl 1):S160-168.
44. 44. Green MS, Cohen D, Lerman Y, et al. Depression of the immune response to an inactivated hepatitis A vaccine administered concomitantly with immune globulin. J Infect Dis. 1993;168:740-743.
45. 45. Newcomer W, Rivin B, Reid R, et al. Immunogenicity, safety and tolerability of varying doses and regimens of inactivated hepatitis A virus vaccine in Navajo children. Pediatr Infect Dis J. 1994;13:640-642.
46. 46. Kruppenbacher J, Bienzle U, Bock HL, Clemens R. Co-administration of an inactivated hepatitis A vaccine with other travellers vaccines: interference with the immune response In: 1994 Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). American Society for Microbiology, 1994:256. Abstract H115.
47. 47. Shaw FE, Shapiro CN, Welty TK, Dill W, Reddington J, Hadler SC. Hepatitis transmission among the Sioux Indians of South Dakota. Am J Public Health. 1990;80:1091-1094.
48. 48. Bulkow LR, Wainwright RB, McMahon BJ, Middaugh JP, Jenkerson SA, Margolis HS. Secular trends in hepatitis A virus infection among Alaska Natives. J Infect Dis. 1993;168:1017-1020.
49. 49. Shapiro CN, Coleman PJ, McQuillan GM, Alter MJ, Margolis HS. Epidemiology of hepatitis A: seroepidemiology of risk groups in the USA. Vaccine. 1992;10(suppl 1):S59-62.
50. 50. Tettmar RE, Masterton RG, Strike PW. Hepatitis A immunity in British adults: an assessment of the need for pre-immunisation screening. J Infect. 1987;15:39-43.
51. 51. Parry JV, Farrington CP, Perry KR, Waight PA, Mortimer PP, Miller E. Rational program for screening travellers for antibodies to hepatitis A virus. Lancet. 1988;i:1447-1449.
52. 52. Centers for Disease Control. Hepatitis A among homosexual men: United States, Canada, and Australia. MMWR. 1992;41:155-164.
53. 53. Lowry PW, Levine R, Stroup DF, Gunn RA, Wilder MH, Konigsberg C. Hepatitis A outbreak on a floating restaurant in Florida. Am J Epidemiol. 1989;129:155-164.
54. 54. Panel discussion. Prospects for control of hepatitis A. Vaccine. 1992;10(suppl 1):S170-174.
55. 55. Centers for Disease Control. Communitywide outbreaks of hepatitis A: hepatitis surveillance report no. 51. Atlanta: CDC, 1987;6-8.
56. 56. Shaw FE, Sudman JH, Smith SM, et al. A community-wide epidemic of hepatitis A in Ohio. Am J Epidemiol. 1986;123:1057-1065.
57. 57. Centers for Disease Control. Hepatitis A among persons with hemophilia who received clotting factor concentrate: United States, September-December 1995. MMWR. 1996;45:29-32.
58. 58. Shapiro CN, Hadler SC. Significance of hepatitis in children in daycare. Semin in Pediatr Infect Dis. 1990;1:270-279.
59. 59. Hadler SC, Webster HM, Erben JJ, Swanson JE, Maynard JE. Hepatitis A in day-care centers: a communitywide assessment. NEJM. 1980;302:1222-1227.
60. 60. Lemon SM, Shapiro CN. The value of immunization against hepatitis A. Infect Agents Dis. 1994;1:38-49.
61. 61. Jackson LA, Stewart LK, Solomon SL, et al. Risk of infection with hepatitis A, B, or C, cytomegalovirus, varicella, or measles among child care providers. Pediatr Infect Dis J. 1996;15:584-589.
62. 62. Kashiwagi S, Hayashi J, Ikematasu H, et al. Prevalence of immunologic markers of hepatitis A and B infection in hospital personnel in Miyazaki Prefecture, Japan. Am J Epidemiol. 1985;122:960-969.
63. 63. Gibas A, Blewett DR, Schoenfeld DA, Dienstag JL. Prevalence and incidence of viral hepatitis in health workers in the prehepatitis B vaccination era. Am J Epidemiol. 1992;136:603-610.
64. 64. Edgar WM, Campbell AD. Nosocomial infection with hepatitis A. J Infect. 1985;10:43-47.
65. 65. Hofmann F, Wehrle G, Berthold H, Koster D. Hepatitis A as an occupational hazard. Vaccine. 1992;10(suppl 1):S82-84.
66. 66. Noble RC, Kane MA, Reeves SA, Roeckel I. Postransfusion hepatitis A in a neonatal intensive care unit. JAMA. 1984;252:2711-2715.
67. 67. Azimi PH, Roberto RR, Guralnik J, et al. Transfusion-acquired hepatitis A in a premature infant with secondary nosocomial spread in an intensive care nursery. Am J Dis Child. 1986;140:23-27.
68. 68. Rosenblum LS, Villarino ME, Nainan OV, et al. Hepatitis A outbreak in a neonatal intensive care unit: risk factors for transmission and evidence of prolonged viral excretion among preterm infants. J Infect Dis. 1991;164:476-482.
69. 69. Drusin LM, Sohmer M, Groshen SL, Spiritos MD, Senterfit LB, Christenson WN. Nosocomial hepatitis A infection in a paediatric intensive care unit. Arch Dis Child. 1987;62:690-695.
70. 70. Giacoia GP, Kasprisin DO. Transfusion-acquired hepatitis A. South Med J. 1989;82:1357-1360.
71. 71. Dienstag JL, Davenport FM, McCollum RW, Hennessy AV, Klatskin G, Purcell RH. Nonhuman primate-associated viral hepatitis type A: serologic evidence of hepatitis A virus infection. JAMA. 1976;236:462-464.
72. 72. Coutinho RA, Albrecht-van Lent P, Lelie N, Nagelkerke N, Kuipers H, Rijsdijk T. Prevalence and incidence of hepatitis A among homosexuals. Br Med J. 1983;287:1743-1745.
73. 73. Centers for Disease Control. Protection against viral hepatitis; recommendation of the immunization practices advisory committee (ACIP). MMWR. 1990;39:1-26.
74. 74. Matthew EB, Dietzman DE, Madden DL, et al. A major epidemic of infectious hepatitis in an institution for the mentally retarded. Am J Epidemiol. 1973;98:199-215.
75. 75. Szmuness W, Purcell RH, Dienstag JL, Stevens CE. Antibody to hepatitis A antigen in institutionalized mentally retarded patients. JAMA. 1977;237:1702-1705.
76. 76. Lehmann NI, Sharma DLB, Gust ID. Prevalence of antibody to the hepatitis A virus in a large institution for the mentally retarded. J Med Virol. 1978;2:335-339.
77. 77. Centers for Disease Control. Hepatitis A among drug users. MMWR. 1988;37:297-305.
78. 78. Harkess J, Gildon B, Istre GR. Outbreaks of hepatitis A among illicit drug users, Oklahoma 1984-87. Am J Public Health. 1989;79:463-466.
79. 79. Steffen R, Rickenbach M, Wilhelm U, Helminger A, Schar M. Health problems after travel to developing countries. J Infect Dis. 1987;156:84-91.
80. 80. Hoke CH, Binn LN, Egan JE, et al. Hepatitis A in the US army: epidemiology and vaccine development. Vaccine. 1992;10(suppl 1): S75-80.
81. 81. Muller R, Chriske H, Deinhardt F, et al. Hepatitis A vaccination: schedule for accelerated immunization. Vaccine. 1992;10(suppl 1): S124-125.
82. 82. Shaw FE, Sudman JH, Smith SM, et al. A community-wide epidemic of hepatitis A in Ohio. Am J Epidemiol. 1986;123:1057-1065.
83. 83. Desenclos JA, Klontz KC, Wilder MH, Nainan OV, Margolis HS, Gunn RA. A multistate outbreak of hepatitis A caused by the consumption of raw oysters. Am J Public Health. 1991;81:1268-1272.
84. 84. Eisenstein AB, Aach RD, Jacobsohn W, Goldman A. An epidemic of infectious hepatitis in a general hospital; probable transmission by contaminated orange juice. JAMA. 1963;185:171-174.
85. 85. Meyers JD, Romm FJ, Tihen WS, Bryan JA. Food-borne hepatitis A in a general hospital: epidemiologic study of an outbreak attributed to sandwiches. JAMA. 1975;231:1049-1053.
86. 86. Portnoy BL, Mackowiak PA, Caraway CT, Walker JA, McKinley TW, Klein CA. Oyster associated hepatitis: failure of shellfish certification programs to prevent outbreaks. JAMA. 1975;233:1065-1068.
87. 87. Levy BS, Fontaine RE, Smith CA, et al. A large food-borne outbreak of hepatitis A. JAMA. 1975;234:289-294.
88. 88. Lowry PW, Levine R, Stroup DF, Gunn RA, Wilder MH, Konigsberg C. Hepatitis A outbreak on a floating restaurant in Florida. Am J Epidemiol. 1989;129:155-164.
89. 89. Niu MT, Polish LB, Robertson BH, et al. Multistate outbreak of hepatitis A associated with frozen strawberries. J Infect Dis. 1992; 166:518-524.
90. 90. Rosenblum LS, Mirkin IR, Allen DT, Safford S, Hadler SC. A multifocal outbreak of hepatitis A traced to commercially distributed lettuce. Am J Public Health. 1990;80:1075-1080.
91. 91. Francis DP, Maynard JE. The transmission and outcome of hepatitis A, B, and non-A, non-B: a review. Epidemiol Rev. 1979;1:17-31.
92. 92. Hadler SC. Global impact of hepatitis A virus infection: changing patterns. In: Hollinger FB, Lemon SM, Margolis HS, eds. Viral Hepatitis and Liver Disease. Baltimore: Williams & Wilkens; 1991:14-20.
93. 93. Akriviadis EA, Redeker AG. Fulminant hepatitis A in intravenous drug users with chronic liver disease. Ann Intern Med. 1989;110: 838-839.
94. 94. Centers for Disease Control and Prevention. Hepatitis Surveillance Report.. 1994:1-56.
95. 95. Rajan E, Albloushi S, O'Farrell B, Shattock A, Courtney MG, Fielding JF. Nurses in a general adult hospital are also at increased risk of hepatitis A infection. Am J Gastroenterol. 1993;88:1555A. Abstract.
96. 96. Naus M, Everett W, Davies S, Coutts J. A school outbreak of hepatitis A in South Western Ontario. Can Dis Weekly Rep. 1989;15:225-228.
97. 97. Ambrosch F, Wiedermann G, Andre FE, et al. Clinical and immunological investigation of a new combined hepatitis A and B vaccine. J Med Virol. 1994;44:452-456.